320 filings
Page 2 of 16
8-K
bmy3vtv
5 Dec 23
Entry into a Material Definitive Agreement
5:04pm
8-K
e21emwpbwfux5bjsyi4n
6 Nov 23
Amendments to Articles of Incorporation or Bylaws
8:21pm
DEF 14C
uuk 8wrogv9xsdmvo
16 Oct 23
Information statement
6:16pm
8-K
nt7fqrm499ooh
3 Oct 23
Departure of Directors or Certain Officers
4:34pm
PRE 14C
vo61anf
3 Oct 23
Preliminary information
4:12pm
8-K
g6vdgww2 s1o
7 Sep 23
Skye Bioscience Reverse Stock Split to be Effective on September 8th
1:15pm
8-K/A
dcrp08qjupym14u84trv
1 Sep 23
Departure of Directors or Certain Officers
12:00am
D
hh4q7wyvqjo4hde l6rq
29 Aug 23
$62.25 mm in equity / debt / options / securities to be acquired, sold $62.25 mm, 12 investors
4:56pm
8-K
n19aak c2xfi8
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K/A
djydxirar5xayb9k gan
27 Mar 23
Departure of Directors or Certain Officers
4:09pm
8-K
v74lmwp73jwurlk7tt
23 Feb 23
Entry into a Material Definitive Agreement
5:18pm
8-K
8hc1oni33g8h3 k4pil
16 Feb 23
Skye Bioscience Appoints Deborah Charych, PhD to Board of Directors
5:16pm
8-K
4h662
15 Feb 23
Skye Bioscience Closes Sale of Subsidiary, Verdélite Sciences, to C3 Souvenir Holding, with USD$5.60M Closing Payment
4:26pm
8-K
l70fgfr
26 Jan 23
Entry into a Material Definitive Agreement
9:22pm
8-K
g1evya 2csy9fat
6 Jan 23
Entry into a Material Definitive Agreement
4:57pm
8-K
fh7joq
16 Dec 22
Entry into a Material Definitive Agreement
6:40pm